Vaxart (STU:NB11) YoY Rev. per Sh. Growth : 608.33% (As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is Vaxart YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Vaxart's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 was 608.33%.

Vaxart's Revenue per Share for the three months ended in Mar. 2025 was €0.09.

Vaxart YoY Rev. per Sh. Growth Historical Data

The historical data trend for Vaxart's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaxart YoY Rev. per Sh. Growth Chart

Vaxart Annual Data

Trend

Jun15

Jun16

Jun17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

-90.75

-84.21

-83.33

4,600.00

189.36

Vaxart Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															500.00	-	566.67	48.84	608.33

Vaxart YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Vaxart's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2024 )
=	(Revenue per Share (A: Dec. 2024 )	-	Revenue per Share (A: Dec. 2023 ))	/	\| Revenue per Share (A: Dec. 2023 ) \|
=	(0.136	-	0.047)	/	\| 0.047 \|
=	189.36 %

Vaxart's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY Rev. per Sh. Growth (Q: Mar. 2025 )
=	(Revenue per Share (Q: Mar. 2025 )	-	Revenue per Share (Q: Mar. 2024 ))	/	\| Revenue per Share (Q: Mar. 2024 )) \|
=	(0.085	-	0.012)	/	\| 0.012 \|
=	608.33 %

Vaxart YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Vaxart's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Vaxart Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxart Inc (STU:NB11) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

VXRT:USA NB11:Germany

Address

170 Harbor Way, Suite 300, South San Francisco, CA, USA, 94080

Website

https://www.vaxart.com

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines based on its Vector Adjuvant Antigen Standardized Technology to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Vaxart Headlines

No Headlines